Five-year Angiographic Follow-up of the Bioabsorbable Vascular Solutions (BVS) Everolimus Eluting Coronary Stent System.

Five-year Angiographic Follow-up of the Bioabsorbable Vascular Solutions (BVS) Everolimus Eluting Coronary Stent System. - BVS-FYRA

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON36133

Enrollment

Registered

2011-11-28

Start date

2011-06-01

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary artery disease

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Previous inclusion in the *BVS Everolimus Eluting Coronary Stent System-First in Man (FIM) Clinical Investigation: Cohort A (05-370)*. Signed Informed Consent

Exclusion criteria

Exclusion criteria: Left ventricular ejection fraction

Design outcomes

Primary

Measure	Time frame
In this study the outcome is focussed on angiographic results, including IVUS, OCT, vasomotion and palpography, measuring i.e. in-stent late loss (LL), in-segment LL, vessel area, lumen area, in-stent %Volume obstruction, mean coronary segment diameter change from baseline after maximal endothelium-dependent vasodilation, at least 5-years post-procedure.	—

Secondary

Measure	Time frame
nvt	—

Countries

Netherlands

Outcome results